
Halozyme to Present Virtually at the 40th Annual J.P. Morgan Health Care Conference
SAN DIEGO: SAN DIEGO, Jan. 4, 2022 /PRNewswire/ — Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that Dr. Helen Torley, president and chief executive officer, will present virtually at the 40th Annual J.P. Morgan Health […]